Recent Finacing
Recent Raise
Alternative Bio develops therapeutics targeting a previously untapped class of post-translational modifying enzymes, using a discovery platform to identify and advance drug candidates for intractable cancers.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
